Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Beyond saving developer hours, the true value of AI-driven efficiency lies in reducing rework. This frees up capacity for new revenue-generating projects. Frame the value not just as time saved, but as the business value of features you can now build instead (cost of delay).

Related Insights

To quantify the real-world impact of its AI tools, Block tracks a simple but powerful metric: "manual hours saved." This KPI combines qualitative and quantitative signals to provide a clear measure of ROI, with a target to save 25% of manual hours across the company.

Don't just report on leading indicators like faster cycle times. You must explicitly connect them to forecasted lagging outcomes. Present a clear narrative showing how today's efficiency gain will translate into future revenue or cost savings, providing a range of potential impacts.

Instead of focusing on headcount reduction, Goldman's CIO measures the success of developer AI tools by their ability to consistently help projects finish ahead of schedule. This provides a tangible metric for increased output and organizational capacity.

Unlike traditional software that optimizes for time-in-app, the most successful AI products will be measured by their ability to save users time. The new benchmark for value will be how much cognitive load or manual work is automated "behind the scenes," fundamentally changing the definition of a successful product.

Demanding a direct, line-item ROI for foundational AI initiatives is like asking for the ROI on Wi-Fi—it's the wrong question. Instead of getting bogged down in impossible calculations, leaders should focus on measuring the business outcomes enabled by the technology, such as innovation speed or new product creation. Obsess on outcomes, not direct financial return.

Businesses are unlikely to use powerful AI simply to shave a few percentage points off their software spend. The real, high-impact ROI comes from applying AI to improve core business operations, making the actual business more effective and efficient.

A traditional IT investment ROI model misses the true value of AI in pharma. A proper methodology must account for operational efficiencies (e.g., time saved in clinical trials, where each day costs millions) and intangible benefits like improved data quality, competitive advantage, and institutional learning.

Leaders often expect AI to produce a shiny, marketable feature. When AI’s value is 'invisible'—baked into workflows to improve efficiency—translate those gains into concrete financial outcomes like cost savings or accelerated revenue, rather than focusing on the process improvements themselves.

Abstract 'time savings' are hard for executives to grasp. The most powerful way to demonstrate AI's value is showing how increased productivity allows the company to achieve its goals without making previously planned hires. This converts efficiency into an undeniable budget line item.

Vanity metrics like "AI lines of code" are misleading. Coinbase measures AI success by its impact on the end-to-end development cycle: the total time from a ticket's creation to the change landing with a user. This metric holistically captures gains and focuses the team on true velocity.